Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN)

56 filings reported holding VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q2 2025.
Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 14,875,235 shares of 31,887,528 outstanding shares and own 47% of the company stock.
Largest 10 shareholders include TCG Crossover Management, LLC (2,676,580 shares), Nantahala Capital Management, LLC (1,978,492 shares), STEMPOINT CAPITAL LP (1,796,505 shares), VANGUARD GROUP INC (1,759,642 shares), Commodore Capital LP (1,575,000 shares), JPMORGAN CHASE & CO (748,862 shares), Ikarian Capital, LLC (601,703 shares), SPHERA FUNDS MANAGEMENT LTD. (447,939 shares), ADAR1 Capital Management, LLC (420,765 shares), and BlackRock, Inc. (416,889 shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.